S&P 500 Futures
(-0.15%) 5 205.00 points
Dow Jones Futures
(-0.11%) 39 150 points
Nasdaq Futures
(-0.23%) 18 146 points
Oil
(0.49%) $79.38
Gas
(0.37%) $2.20
Gold
(-0.02%) $2 321.90
Silver
(0.97%) $27.87
Platinum
(0.65%) $991.00
USD/EUR
(0.08%) $0.931
USD/NOK
(0.15%) $10.91
USD/GBP
(0.08%) $0.801
USD/RUB
(0.28%) $91.99

Aktualne aktualizacje dla Hypera S.A. [HYPMY]

Giełda: OTC Sektor: Healthcare Branża: Drug Manufacturers—Specialty & Generic
Ostatnio aktualizowano8 geg. 2024 @ 22:53

-0.93% $ 5.93

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 22:53):

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
Dzisiejszy wolumen 2 273.00
Średni wolumen 10 418.00
Kapitalizacja rynkowa 3.75B
EPS $0.782 ( 2023-09-30 )
Następna data zysków ( $0 ) 2024-07-25
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 11.19
ATR14 $0 (0.00%)

Hypera S.A. Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hypera S.A. Finanse

Annual 2023
Przychody: $7.91B
Zysk brutto: $4.85B (61.30 %)
EPS: $2.61
FY 2023
Przychody: $7.91B
Zysk brutto: $4.85B (61.30 %)
EPS: $2.61
FY 2022
Przychody: $7.55B
Zysk brutto: $4.76B (63.10 %)
EPS: $2.68
FY 2021
Przychody: $5.94B
Zysk brutto: $3.80B (64.05 %)
EPS: $2.11

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.91%) | Divividend Growth Potential Score: 5.92 - Stable (18.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.13 --
Div. Sustainability Score 9.59
Div.Growth Potential Score 5.92
Div. Directional Score 7.75 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.14 %
Dividend Stability
0.49 Below Average
Dividend Score
4.13
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
THVB Ex Dividend Knight 2023-06-14 Semi-Annually 0 0.00%
HMLN Ex Dividend Junior 2023-06-13 Annually 0 0.00%
ANPDY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
PFLC Ex Dividend Knight 2023-08-10 Quarterly 0 0.00%
DBOEY Ex Dividend Junior 2023-05-17 Annually 0 0.00%
UOVEY Ex Dividend Knight 2023-08-04 Annually 0 0.00%
JMPLY Ex Dividend Junior 2023-06-15 Semi-Annually 0 0.00%
BHWB Ex Dividend Knight 2023-07-27 Quarterly 0 0.00%
RSTRF Ex Dividend Knight 2023-09-19 Semi-Annually 0 0.00%
ERMAY Ex Dividend Junior 2023-05-25 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2121.5005.778.65[0 - 0.5]
returnOnAssetsTTM0.06041.2007.999.58[0 - 0.3]
returnOnEquityTTM0.1491.5009.4510.00[0.1 - 1]
payoutRatioTTM0.0801-1.0009.20-9.20[0 - 1]
currentRatioTTM1.8070.8005.974.77[1 - 3]
quickRatioTTM1.3140.8006.985.58[0.8 - 2.5]
cashRatioTTM0.6621.5007.4310.00[0.2 - 2]
debtRatioTTM0.378-1.5003.69-5.54[0 - 0.6]
interestCoverageTTM2.281.000-0.266-0.266[3 - 30]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
freeCashFlowPerShareTTM1.8662.009.0710.00[0 - 20]
debtEquityRatioTTM0.910-1.5006.36-9.54[0 - 2.5]
grossProfitMarginTTM0.6151.0003.093.09[0.2 - 0.8]
operatingProfitMarginTTM0.3271.0005.455.45[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1831.000-0.0935-0.0935[0.2 - 2]
assetTurnoverTTM0.2860.800-1.429-1.143[0.5 - 2]
Total Score9.59

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM11.301.0008.960[1 - 100]
returnOnEquityTTM0.1492.509.6510.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.8662.009.3810.00[0 - 30]
dividendYielPercentageTTM0.1761.5005.600[0 - 0.4]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
payoutRatioTTM0.08011.5009.20-9.20[0 - 1]
pegRatioTTM0.03971.500-3.070[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2431.0006.430[0.1 - 0.5]
Total Score5.92

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej